Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Under 2 Years Old
Status:
Not yet recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
The object of the trial is to evaluate if point-of-care testing directed use of oral
prednisolone is beneficial in acute wheezing induced by rhinovirus in children 6-24 months
old.